Position statement from the Indian Society of Gastroenterology, Cardiological Society of India, Indian Academy of Neurology and Vascular Society of India on gastrointestinal bleeding and endoscopic procedures in patients on antiplatelet and/or anticoagulant therapy

Anil Arora, Ashish Kumar,Anil C. Anand,Ajay Kumar, Ajay Yadav,Ajit Bhagwat,Ajit S. Mullasari,Ambarish Satwik,Anoop Saraya,Ashwani Mehta,Debabrata Roy,Duvvur Nageshwar Reddy,Govind Makharia, Jagarapudi M. K. Murthy, Jayanta Roy, Jitendra P. S. Sawhney,Kameshwar Prasad,Mahesh Goenka,Mathew Philip, Meenakshisundaram Umaiorubahan, Nakul Sinha, Padinhare P. Mohanan,Padmavathy N. Sylaja, Pinjala Ramakrishna,Prafulla Kerkar,Praveer Rai,Rakesh Kochhar,Rakesh Yadav,Sandeep Nijhawan,Saroj K. Sinha, Shirish M. Hastak, Sidharth Viswanathan,Uday C. Ghoshal,Unnikrishnan Madathipat, Vijay Thakore,Vinay Dhir,Vivek A. Saraswat,Zaheer Nabi

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology(2023)

引用 1|浏览11
暂无评分
摘要
Antiplatelet and/or anticoagulant agents (collectively known as antithrombotic agents) are used to reduce the risk of thromboembolic events in patients with conditions such as atrial fibrillation, acute coronary syndrome, recurrent stroke prevention, deep vein thrombosis, hypercoagulable states and endoprostheses. Antithrombotic-associated gastrointestinal (GI) bleeding is an increasing burden due to the growing population of advanced age with multiple comorbidities and the expanding indications for the use of antiplatelet agents and anticoagulants. GI bleeding in antithrombotic users is associated with an increase in short-term and long-term mortality. In addition, in recent decades, there has been an exponential increase in the use of diagnostic and therapeutic GI endoscopic procedures. Since endoscopic procedures hold an inherent risk of bleeding that depends on the type of endoscopy and patients’ comorbidities, in patients already on antithrombotic therapies, the risk of procedure-related bleeding is further increased. Interrupting or modifying doses of these agents prior to any invasive procedures put these patients at increased risk of thromboembolic events. Although many international GI societies have published guidelines for the management of antithrombotic agents during an event of GI bleeding and during urgent and elective endoscopic procedures, no Indian guidelines exist that cater to Indian gastroenterologists and their patients. In this regard, the Indian Society of Gastroenterology (ISG), in association with the Cardiological Society of India (CSI), Indian Academy of Neurology (IAN) and Vascular Society of India (VSI), have developed a “Guidance Document” for the management of antithrombotic agents during an event of GI bleeding and during urgent and elective endoscopic procedures.
更多
查看译文
关键词
Acenocoumarol,Antithrombotic agents,Apixaban,Dabigatran,Direct-acting anticoagulants,Edoxaban,Endoscopy,Factor Xa inhibitors,Fondaparinux,Gastrointestinal hemorrhage,Heparin,Rivaroxaban,Thrombosis,Warfarin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要